Amino Science Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
🔥 FREE SHIPPING ON ORDERS OVER $250 🔥

Research Peptide
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) first isolated from human plasma in 1973. This bioactive peptide demonstrates remarkable tissue regenerative properties, enhancing wound healing, collagen synthesis, and cellular repair mechanisms. Research shows GHK-Cu modulates expression of over 30% of human genes, promoting tissue remodeling while suppressing inflammatory pathways. The peptide increases collagen production by up to 70%, accelerates wound healing by 30-50%, and reduces wrinkle depth by 33%. GHK-Cu levels decline from 200 ng/mL at age 20 to 80 ng/mL by age 60, correlating with decreased regenerative capacity. Studies demonstrate improvements in skin density, hair follicle enlargement, and DNA repair gene activation, making it valuable for anti-aging applications and tissue restoration.
Fast shipping
Same-day dispatch
Third-party tested
U.S. accredited labs
99%+ purity
HPLC verified
3
AMINO ACIDS
Gly-His-Lys + Copper(II)
70%
COLLAGEN BOOST
Synthesis increase in vitro studies
140+
PUBLICATIONS
Since discovery by Dr. Pickart in 1973
1985
FIRST COMMERCIAL USE
In cosmetics & wound care
340Da
MOL. WEIGHT
Copper-binding tripeptide
Free shipping
on orders over $150
Quality guarantee
99%+ purity verified
Secure checkout
256-bit SSL encryption
Research
This listing supplies GHK-Cu — the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine — as a lyophilized reference material for in-vitro and preclinical laboratory work. Unlike a metal-free peptide, GHK-Cu is a coordinated metallopeptide: the histidine imidazole nitrogen, the terminal glycine amine, and adjacent backbone atoms form a chelation site that holds a single copper(II) ion in a stable but exchangeable configuration. That bound copper gives the solid its characteristic blue tint and defines much of the compound's chemistry, so laboratories treat it as a copper complex rather than a simple linear tripeptide when planning identity checks, solvent selection, and storage.
The material is intended for researchers characterizing copper-peptide behavior on the bench. It is used as an isolated standalone compound and, in some catalogs, as the copper-peptide component of multi-sequence research blends where matrix-model interactions are studied under controlled conditions. All descriptions below concern the research substance itself — its documented study history, its analytical fingerprint, and standard handling of freeze-dried peptide reference material — and are not statements about outcomes in humans or animals.
GHK was first isolated from human plasma in the 1970s, and its reported age-related change in biological fluids helped establish it as a recurring subject in matrix-biology and copper-chemistry research. The evidence base is preclinical and in-vitro; the summaries below describe observations in laboratory models, not effects in people, and remain preliminary and ongoing rather than settled.
Research Context
Findings for GHK-Cu derive from isolated-cell, animal-model, and coordination-chemistry studies. They are hypothesis-generating, have not been established as clinical outcomes, and are provided here as neutral scientific background — not as medical advice or a claim of safety or efficacy.
For reproducible work, identity and purity of a copper-peptide standard matter as much as the sequence. GHK-Cu is typically assessed by reversed-phase HPLC to quantify peptide purity, with mass spectrometry used to confirm molecular identity and the expected copper-complex mass. Because the coordinated copper ion alters chromatographic retention and ionization relative to the metal-free peptide, analytical methods for GHK-Cu are usually documented separately, and reviewers should confirm that a reported purity reflects the copper complex rather than the apo-peptide.
A batch-specific certificate of analysis (COA) generally reports the HPLC purity percentage and the mass-spectrometry identity confirmation, and may include water content or residual-solvent data for the lyophilized powder. Because purity, counterion, and copper stoichiometry can vary between manufacturing lots, laboratories are encouraged to review the lot-specific COA rather than a generic specification, and to retain it alongside experimental records to support traceability and reproducibility.
The following describes conventional handling of lyophilized research peptides and is not instruction for human or animal use. Sealed GHK-Cu powder is kept protected from light, humidity, and heat. Because the complex carries a redox-active copper ion, exposure to light and oxidizing conditions is minimized, and solvent choice is documented per protocol since certain buffer components can interact with the copper center. Reconstituted and working solutions are prepared fresh where possible and handled under the temperature conditions shown in the storage specifications on this page.
It is supplied as a lyophilized (freeze-dried) powder for laboratory reconstitution. The bound copper(II) ion typically gives the solid a faint blue tint, distinguishing it visually from metal-free peptides. Refer to the molecular profile and storage specifications elsewhere on this page for the exact form, formula, and temperature guidance for this batch.
The coordinated copper(II) ion changes the molecule's mass, color, and chromatographic behavior. As a result, HPLC and mass-spectrometry methods are documented separately for the complex, and a reported purity should reflect the copper-bound species rather than the apo-peptide. This is why identity confirmation on the COA specifically references the expected copper-complex mass.
Look for the reversed-phase HPLC purity percentage and the mass-spectrometry identity confirmation for the copper complex, plus any water-content or residual-solvent data for the lyophilized powder. Because purity, counterion, and copper stoichiometry can differ between lots, use the batch-specific COA rather than a generic specification and archive it with your experimental records.
In laboratory settings it has served as a model compound for copper-coordination chemistry, copper-transport hypotheses, and in-vitro gene-expression studies in fibroblast and skin-model systems, along with formulation and stability work. These are preclinical and in-vitro observations that remain preliminary and do not establish outcomes in humans or animals.
Yes. Because GHK-Cu contains a redox-active copper ion, storage minimizes exposure to light and oxidizing conditions, and solvent and buffer choice is documented per protocol since some components can interact with the copper center. Follow the lyophilized and reconstituted storage conditions listed in the specifications on this page and your institution's safety requirements.
This product is sold strictly for in-vitro research and laboratory use only. It is not intended for human or animal consumption, diagnostic purposes, or therapeutic application.
By purchasing this product, you confirm that you are a qualified researcher operating within an appropriate laboratory environment and will use this compound in accordance with all applicable local, state, and federal regulations.
Amino Science Labs assumes no liability for misuse of this product outside of its intended research application.
No. GHK-Cu here is a research chemical sold strictly for in-vitro and laboratory research use. It is not for human or animal consumption, diagnostic, or therapeutic purposes. Nothing in this content is medical advice or a claim of safety or efficacy.